Orientation note

What sermorelin is, in plain words

First, see how the signal works. Then split past drug use from what a pharmacy may make now.

Flat geometric illustration of a small yellow signal moving through blue and red blocks toward a black square

The name

A signal, not growth hormone itself

Sermorelin is made in a lab. It copies the first 29 building blocks of a natural hormone made in the brain. That hormone is called growth hormone-releasing hormone.note

It sends a message to the pituitary, a small gland under the brain. The message tells the gland to release growth hormone.

It needs that gland to work. It cannot help when the pituitary has lost all ability to make growth hormone.note

Then

The old approval was narrow

The FDA first approved sermorelin in December 1990 for a test that shows whether the pituitary gland can release growth hormone. It approved another use for certain children with growth failure in September 1997.note

The maker later stopped selling both Geref (sermorelin) products and asked the FDA to withdraw them. The FDA did so on June 18, 2009.note

In 2013, the FDA said the products were not withdrawn for safety or effectiveness reasons.note

As of September 2026, that 2013 statement does not approve any sermorelin product offered now.

Now

Sermorelin has never been approved for adult wellness

As of September 2026, FDA approval has never covered sermorelin for adult energy, sleep, body shape, or anti-aging care.note

As of September 2026, some growth hormone medicines are approved for adults with diagnosed growth hormone deficiency. Sermorelin is not one of them.note

A useful pause: ask what condition is being treated, why sermorelin fits that condition, and what adult evidence supports the plan.

Next note

Decode the words around the offer

Terms like compounded, approved, and outsourcing facility are not interchangeable.

Go to the glossary →

Page notes

  1. PubMed: clinical review of sermorelin
  2. FDA briefing on growth-hormone signals and gland function
  3. Federal Register: Geref indications and approval history
  4. Federal Register: withdrawal of the Geref approvals
  5. Federal Register decision about the withdrawn products
  6. FDA briefing on approved uses in adults